To characterize HS and CS glycan structures from EXTL2 KO and EXTL3 KO glycoengineered cancer cell lines, we isolated and purified cellular GAGs and performed HS and CS disaccharide analyses using reversed-phase ion pair HPLC (RPIP-HPLC). The gene discussed is EXTL3; the disease is cancer.